Citable segment mix
MCK's latest SEC segment disclosure for revenue by segment shows North American Pharmaceutical as the largest listed segment at $86.77B (82.3% of disclosed segment revenue).
| Segment | Period | Revenue | Mix |
|---|---|---|---|
| North American Pharmaceutical | Jun 30, 2026 | $86.77B | 82.3% |
| Oncology & Multispecialty | Jun 30, 2026 | $14.22B | 13.5% |
| Medical-Surgical Solutions | Jun 30, 2026 | $2.82B | 2.7% |
| Prescription Technology Solutions | Jun 30, 2026 | $1.57B | 1.5% |
Source: SEC EDGAR segment disclosures; period Jun 30, 2026.
MCK company research is available with Aerarium Pro (CAD $10/mo). The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay free. Already a subscriber? Sign in to pick up where you left off.